M
Mitesco Inc
OTC:MITI
Mitesco Inc
OTC:MITI
Price:
0.109
USD
-0.91%
Market Cap:
$1.9m
Mitesco Inc
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Mitesco Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mitesco Inc
OTC:MITI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Research & Development
-$359.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Mitesco Inc
Glance View
Mitesco, Inc. engages in the development, production, and sale of pharmaceuticals. The company is headquartered in Saint Louis Park, Minnesota and currently employs 24 full-time employees. The company went IPO on 2011-11-03. The firm is focused on acquisition of compounding pharmacy companies. The company is also focused on developing a portfolio of companies that provide healthcare technology solutions. Its operations are based on establishing medical clinics utilizing nurse practitioners under The Good Clinic name and development and acquisition of telemedicine technology. The company has opened its first The Good Clinic in Minneapolis, Minnesota.
MITI
Intrinsic Value
0.012
USD
Overvaluation 89%
M
